Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Accumulated Expenses (2016 - 2025)

Dolby Laboratories' Accumulated Expenses history spans 17 years, with the latest figure at $376.2 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 4.24% year-over-year to $376.2 million; the TTM value through Dec 2025 reached $376.2 million, up 4.24%, while the annual FY2025 figure was $369.3 million, 6.25% up from the prior year.
  • Accumulated Expenses reached $376.2 million in Q4 2025 per DLB's latest filing, up from $369.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $376.5 million in Q1 2025 to a low of $225.8 million in Q4 2021.
  • Average Accumulated Expenses over 5 years is $299.0 million, with a median of $299.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: soared 52.62% in 2023, then fell 19.02% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $225.8 million in 2021, then increased by 1.99% to $230.3 million in 2022, then soared by 42.04% to $327.2 million in 2023, then rose by 10.31% to $360.9 million in 2024, then grew by 4.24% to $376.2 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Accumulated Expenses are $376.2 million (Q4 2025), $369.3 million (Q3 2025), and $317.4 million (Q2 2025).